102
Views
19
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Photodynamic therapy with methyl aminolevulinate for atypia/carcinoma in situ of the penis

, , , &
Pages 507-510 | Received 22 Jan 2007, Published online: 09 Jul 2009

References

  • Bowen TJ. Precancerous dermatoses: a study of two cases of chronic atypical epithelial proliferation. J Cutan Dis 1912; 30: 241–55
  • Queyrat L. Erythroplasie du gland. Bull Soc Franc Derm Syph 1911; 22: 372–8
  • Horenblas S, von Krogh G, Cubilla AL, Dillner J, Meijer CJ, Hedlund PO. Squamous cell carcinoma of the penis: premalignant lesions. Scand J Urol Nephrol Suppl 2000; 205: 187–8
  • Van Bezooijen BP, Horenblas S, Meinhardt W, Newling DW. Laser therapy for carcinoma in situ of the penis. J Urol 2001; 166: 1670–1
  • Graham JH, Helwig EB. Erythroplasia of Queyrat. A clinicopathologic and histochemical study. Cancer 1973; 32: 1396–414
  • Rippentrop JM, Joslyn SA, Konety BR. Squamous cell carcinoma of the penis: evaluation of data from the surveillance, epidemiology, and end results program. Cancer 2004; 101: 1357–63
  • Krieg RM, Luk KH. Carcinoma of penis. Review of cases treated by surgery and radiation therapy 1960–1977. Urology 1981; 18: 149–54
  • Goette DK, Carson TE. Erythroplasia of Queyrat: treatment with topical 5-fluorouracil. Cancer 1976; 38: 1498–502
  • Windahl T, Andersson SO. Combined laser treatment for penile carcinoma: results after long-term followup. J Urol 2003; 169: 2118–21
  • Lee MR, Ryman W. Erythroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy. Australas J Dermatol 2005; 46: 196–8
  • Stables GI, Stringer MR, Robinson DJ, Ash DV. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1999; 140: 514–7
  • Zeitouni NC, Shieh S, Oseroff AR. Laser and photodynamic therapy in the management of cutaneous malignancies. Clin Dermatol 2001; 19: 328–38
  • Angell-Petersen E, Sorensen R, Warloe T, Soler AM, Moan J, Peng Q, et al. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 2006; 126: 265–71
  • Henderson BW, Busch TM, Vaughan LA, Frawley NP, Babich D, Sosa TA, et al. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res 2000; 60: 525–9
  • Horenblas S, van Tinteren H. Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol 1994; 151: 1239–43
  • Mikhail GR. Cancers, precancers, and pseudocancers on the male genitalia. A review of clinical appearances, histopathology, and management. J Dermatol Surg Oncol 1980; 6: 1027–35
  • Kaye V, Zhang G, Dehner LP, Fraley EE. Carcinoma in situ of penis. Is distinction between erythroplasia of Queyrat and Bowen's disease relevant?. Urology 1990; 36: 479–82
  • Windahl T, Hellsten S. Laser treatment of localized squamous cell carcinoma of the penis. J Urol 1995; 154: 1020–3
  • Frimberger D, Schneede P, Hungerhuber E, Sroka R, Zaak D, Siebels M, et al. Autofluorescence and 5-aminolevulinic acid induced fluorescence diagnosis of penile carcinoma—new techniques to monitor Nd:YAG laser therapy. Urol Res 2002; 30: 295–300
  • Morton CA, Whitehurst C, McColl JH, Moore JV, MacKie RM. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol 2001; 137: 319–24
  • Paoli J, Ternesten Bratel A, Löwhagen G-B, Stenquist B, Forslund O, Wennberg A-M. Penile intraepithelial neoplasia: results of photodynamic therapy. Acta Dermatol Venereol 2006; 86: 418–21

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.